What is PatentIn and how does it relate to sequence listings?
PatentIn is a software program developed by the USPTO to facilitate compliance with sequence rules for patent applications involving nucleotide and amino acid sequences. It helps applicants generate sequence listings in a format compliant with 37 CFR 1.821-1.825 and WIPO Standard ST.25.
The MPEP states: While use of the PatentIn program is not required for compliance with the sequence rules, its use is highly recommended, as Office experience has shown that submissions developed with PatentIn are far less likely to include errors than those developed without the program.
To learn more:
Topics:
MPEP 2400 - Biotechnology,
MPEP 2430 - Patentin Information,
Patent Law,
Patent Procedure